serological
[대역어] 혈청학의
[용어속성] Term
[용어속성] Term
The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
Immunology
[키워드] adverse effect
Antibody Response
Blood
booster
characterized
clinical
collected
CoronaVac
dominant
Effect
Effects
elicit
epithelial lining
exhibited
first dose
IgA
IgG
IgG response
Immunity
Immunoglobulin
immunoglobulin A
Immunoglobulin G
Immunological response
inactivated
Inactivated virus vaccine
induce
mRNA
mRNA vaccine
mucosal
mucosal immunity
nasal
nasal epithelial lining fluid
neutralization
Neutralizing
Neutralizing activity
neutralizing effect
novel
objective
other tissue
plasma
plasma antibody
plasma sample
quantified
recipient
response
responses
Result
SARS-CoV-2
SARS-CoV-2 S1 protein
SARS-CoV-2 vaccine
serological
serological immunity
subject
subjects
vaccination
Vaccine
virus
widespread
[DOI] 10.3389/fimmu.2021.744887 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.744887 PMC 바로가기 [Article Type] Immunology
Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study
Observational Study
[키워드] absence
Admission
Affect
age
analysed
association
assumption
Clinical management
cohort study
collected data
Community
complications
contribute
coronavirus 2
COVID-19
COVID-19 patient
CrI
Critical
discharge
driver
Evidence
example
exposure to
females
first positive
HCW
HCWs
healthcare worker
high risk
hospital
hospitalised
Hospitalised patients
hospitals
identify
identifying
Improved
incidence
Incubation period
individual
infected patient
infected with SARS-CoV-2
Infection
Infection prevention
infection risk
infections
Isolation
less
limit
limitation
linear
Logistic
measure
Measures
mitigate
nosocomial
Nurses
Observational cohort study
occurred
onward transmission
pathway
Patient
patients
PCR
PCR test
per day
Personal protective equipment
positive
positive SARS-CoV-2 PCR
Prevent
PROTECT
quantified
reduced
reported
researcher
respiratory
risk
risk factor
risk of transmission
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV2 infection
sensitivity analysis
serological
sick
Spread
statistical
study period
Support
susceptible
susceptible individual
susceptible patient
susceptible patients
symptom onset
tested
Transmission
transmission pathway
transmission pathways
United Kingdom
[DOI] 10.1371/journal.pmed.1003816 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1371/journal.pmed.1003816 PMC 바로가기 [Article Type] Observational Study
A Closer Look into FDA-EUA Approved Diagnostic Techniques of Covid-19
COVID-19의 FDA-EUA 승인 진단 기술 자세히 살펴보기
Review
[키워드] 2019 coronavirus disease
acute respiratory syndrome
approved
authorization
caused
coronavirus
COVID-19
diagnostic
diagnostics
disadvantage
drug
Efficiency
FDA-EUA
food
Health
highlight
IMPROVE
molecular
molecular diagnostics
multicountry analysis
provide
resources
serological
serological diagnostics.
similarity
technique
Variation
virus
worldwide pandemic
[DOI] 10.1021/acsinfecdis.1c00268 PMC 바로가기 [Article Type] Review
[DOI] 10.1021/acsinfecdis.1c00268 PMC 바로가기 [Article Type] Review
Prevalence of SARS-CoV-2 antibodies in the Palestinian population: A primary health center-based cross-sectional study
팔레스타인 인구에서 SARS-CoV-2 항체의 유병률: 1차 보건 센터 기반 단면 연구
Clinical Trial
[키워드] 95% CI
95% confidence interval
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
adjusted
Antibody titer
blood sample
Blood samples
Care
Contact
Coronavirus-2
COVID-19
COVID-19 symptom
COVID-19 symptoms
Critical
cross-sectional
cross-sectional study
ELISA
enzyme
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
epidemiological data
Factor
Health
Health care
hypertension
IgA
IgA antibodies
IgA antibody
IgG
IgM
immunization
North
participant
Patient
positive
Predictive
Prevalence
Primary Health Care
public health measure
public health measures
random
Randomly
Region
Regression model
SARS-CoV-2
SARS-CoV-2 antibodies
SARS-CoV-2 antibody
SARS-CoV-2 specific antibodies
SARS-CoV-2 specific antibody
SARS-CoV-2-positive patient
SARS-CoV-2-positive patients
SARS-CoV-2-specific antibodies
selected
serological
Serological testing
Seroprevalence
serum sample
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
Sex
significantly
significantly higher
Smokers
smoking
Specific
specific antibodies
specific antibody
specific IgM
susceptible
tested
total antibodies
total antibody
was used
were assessed
were measured
West Bank
[DOI] 10.1371/journal.pone.0258255 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1371/journal.pone.0258255 PMC 바로가기 [Article Type] Clinical Trial
Epidemiological assessment of the first COVID-19 epidemic wave in Lombardy. A systematic review
롬바르디아의 첫 번째 COVID-19 전염병에 대한 역학 평가. 체계적인 검토
Article
[키워드] addition
carried
China
Contact
contact with
COVID-19
COVID-19 epidemic
death
eligible
epidemic wave
epidemiological
European
extreme
First wave
Grey literature
had no
highlight
Hospital admission
Hospitalization
hospitalizations
incidence
Italian
Italy
knowledge
literature review
lombardy
measure
Mortality
municipality
Outbreaks
positive
recorded
Region
regions
Reproduction number
retrieved
SARS-COV-2 infection
serological
Spread
systematic review
tested
Travel
virus
widespread
Wuhan
[DOI] 10.23750/abm.v92iS6.12340 PMC 바로가기 [Article Type] Article
[DOI] 10.23750/abm.v92iS6.12340 PMC 바로가기 [Article Type] Article
A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array
6-플렉스 항원 어레이에 의한 이스라엘의 COVID-19 초기 단계의 혈청학적 스냅샷
Research Article
[키워드] Analysis
anti-SARS-CoV-2
anti-SARS-CoV-2 antibodies
anti-SARS-CoV-2 antibody
antibody
Antigen
applied
characterization
collected
COVID-19
COVID-19 outbreak
COVID-19 pandemic
COVID-19 patient
COVID-19 patients
cross-reacting antibodies
death
ectodomain
evaluate
FIVE
generate
healthy
healthy subject
IgA antibodies
IgA antibody
IgG
IgM
immune response
immune responses
inactivated
individual
individuals
Israel
Microarray
Microarrays
multiplex
naïve individuals
nonspecific
NTD
nucleocapsid
outbreak
pandemic
Patient
patients
PCR
presenting
Protein
qRT-PCR
quantitative PCR
RBD
resulting
reverse transcription
SARS-CoV-2
SARS-CoV-2 antigen
SARS-CoV-2 seroprevalence
SARS-CoV-2-specific IgG
screened
sensitivity
sera
Seroconversion
serological
serological marker
serology
Specific
specific IgM
specificity
spike
Stage
subunit
symptom onset
symptomatic
trials
Vaccine
Viral
Viral antigen
viral antigens
virus
was used
[DOI] 10.1128/Spectrum.00870-21 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1128/Spectrum.00870-21 PMC 바로가기 [Article Type] Research Article
Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population
나이지리아 인구에서 상용 SARS-CoV-2 면역분석의 검증
Research Article
[키워드] Abbott
Algorithm
anti-SARS-CoV-2
Architect
assay
Bio-rad
caution
Characteristics
China
confirmation
country
COVID-19
COVID-19 pandemic
Disease prevalence
effort
ELISAs
Endemic
enzyme-linked immunosorbent assay
enzyme-linked immunosorbent assays
estimate
Euroimmun
Europe
evaluated
exposure to
FIVE
hepatitis B
highlight
HIV positive
IgG
immunoassay
Immunoglobulin
Immunoglobulin G
IMPROVE
independent
lead
limit
Microparticle
much lower
negative sample
Nigeria
nucleocapsid protein
Omega
pathogen
Pathogens
PCR
PCR-positive patient
plasma
Population
populations
positive
public health
reported
SARS-CoV-2
SARS-CoV-2 IgG
sensitivities
sensitivity
Sensitivity and specificity
serological
Serological assay
serological assays
serology
Seroprevalence
Serosurvey
Serosurveys
Specificities
specificity
specimen
Spread
Total
validation
widespread
[DOI] 10.1128/Spectrum.00680-21 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1128/Spectrum.00680-21 PMC 바로가기 [Article Type] Research Article
Albumin as a Prognostic Indicator in Pre-Intubated Patients With SARS-CoV-2: A Retrospective, Multi-Institutional Study
Internal Medicine
[키워드] 24 hour
acute respiratory syndrome
age
association
Biomarker
Cohort
collected
Coronavirus-2
Corporation
determine
effort
endotracheal
Escalation
evaluated
FIVE
higher risk
Indicator
Infection
initiated
intubation
lab
likelihood
Linear regression
marker
Mortality
multivariate
New York City
nippv
Non-invasive
oxygen
Patient
patients
patients with SARS-CoV-2
positive airway pressure
positive pressure ventilation
Pre-intubation
predict
Prognosis
required
Result
Retrospective study
SARS-CoV-2
SARS-CoV-2 patient
serological
serological marker
serological test
serum
serum albumin
utility
while
worsening
[DOI] 10.7759/cureus.18532 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.18532 PMC 바로가기 [Article Type] Internal Medicine
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
면역 억제를 받는 환자에서 SARS-CoV-2 백신 접종에 대한 체액 및 T 세포 반응
Article
[키워드] antibody
Antibody Response
assays
Autoimmune
Autoimmune diseases
B-cell
B-lymphocytes
BNT162b2
BNT162b2 mRNA
ChAdOx1
ChAdOx1 nCoV-19
ChAdOx1 nCoV-19 vaccines
Combination
COVID-19
detectable
Diseases
Efficacy
Evidence
evidence of
failure
glomerular
glomerular diseases
healthy individuals
immune responses
immunogenic
immunogenicity
Immunological response
Immunosuppression
immunosuppressive
immunosuppressive therapies
immunosuppressive therapy
impair
induce
investigated
Lymphocytes
mounted
non-responder
participant
Patient
preserved
receiving
responders
response
responses
rituximab
robust
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 vaccination
SARS-CoV-2 vaccine
SARS-CoV-2 vaccines
Seroconversion
seroconvert
seroconverted
serological
serology
T-cell ELISpot
T-cell Response
T-cell responses
tacrolimus
therapy
vaccination
Vaccine
vaccine dose
Vaccines
were used
[DOI] 10.1136/annrheumdis-2021-220626 PMC 바로가기 [Article Type] Article
[DOI] 10.1136/annrheumdis-2021-220626 PMC 바로가기 [Article Type] Article